| Citation: |
YAN Xuelian, TANG Bingying, QU Xuan, ZHANG Ning, KANG Lin. A Case Report of Hypothyrotropin Hypothyroidism Caused by Roxadustat[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 519-522. DOI: 10.12290/xhyxzz.2024-0115
|
Roxadustat is the world's first small molecule hypoxia-inducible factor prolyl hydroxylase inhibitor. Its adverse effect of causing hypothyroidism with low thyroid-stimulating hormone (TSH) is relatively rare and manifests subtly in elderly patients with multiple coexisting diseases. This article reports a case of an elderly patient with renal anemia who developed reversible low-TSH hypothyroidism after taking roxadustat for 12 days, with a significant decrease in thyroid hormone levels. After discontinuing roxadustat for 15 days, the thyroid hormone levels gradually returned to normal. Due to the worsening of renal anemia, the patient took roxadustat again, and 9 days later, the thyroid function-related indicators decreased upon re-examination, leading to the initiation of levothyroxine replacement therapy. In conjunction with relevant literature, this article analyzes the adverse reactions that occur during the oral administration of roxadustat in elderly patients with chronic kidney disease, aiming to provide reference for drug treatment of such patients.
| [1] |
Mikhail A, Brown C, Williams J A, et al. Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease[J]. BMC Nephrol, 2017, 18(1): 345. DOI: 10.1186/s12882-017-0688-1
|
| [2] |
Barratt J, Sulowicz W, Schömig M, et al. Efficacy and cardiovascular safety of roxadustat in dialysis-dependent chronic kidney disease: pooled analysis of four phase 3 studies[J]. Adv Ther, 2021, 38(10): 5345-5360. DOI: 10.1007/s12325-021-01903-7
|
| [3] |
Zheng L, Tian J H, Liu D P, et al. Efficacy and safety of roxadustat for anaemia in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: a systematic review and meta-analysis[J]. Br J Clin Pharmacol, 2022, 88(3): 919-932. DOI: 10.1111/bcp.15055
|
| [4] |
Liang Q C, Li X, Niu Q Y, et al. Efficacy and safety of roxadustat in Chinese hemodialysis patients: a systematic review and meta-analysis[J]. J Clin Med, 2023, 12(7): 2450. DOI: 10.3390/jcm12072450
|
| [5] |
Ganz T, Locatelli F, Arici M, et al. Iron parameters in patients treated with roxadustat for anemia of chronic kidney disease[J]. J Clin Med, 2023, 12(13): 4217. DOI: 10.3390/jcm12134217
|
| [6] |
Csiky B, Schömig M, Esposito C, et al. Roxadustat for the maintenance treatment of anemia in patients with end-stage kidney disease on stable dialysis: a European phase 3, randomized, open-label, active-controlled study (PYRENEES)[J]. Adv Ther, 2021, 38(10): 5361-5380. DOI: 10.1007/s12325-021-01904-6
|
| [7] |
Tokuyama A, Kadoya H, Obata A, et al. Roxadustat and thyroid-stimulating hormone suppression[J]. Clin Kidney J, 2021, 14(5): 1472-1474. DOI: 10.1093/ckj/sfab007
|
| [8] |
Ichii M, Mori K, Miyaoka D, et al. Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis[J]. BMC Nephrol, 2021, 22(1): 104. DOI: 10.1186/s12882-021-02304-2
|
| [9] |
施晓婷, 李曼, 崔雯霞, 等. 罗沙司他致血清低促甲状腺激素性甲状腺功能减退1例[J]. 中华内科杂志, 2022, 61(12): 1357-1359. DOI: 10.3760/cma.j.cn112138-20220121-00068
Shi X T, Li M, Cui W X, et al. Hypothyrotropin hypothyroidism caused by roxadustat: a case report[J]. Chin J Intern Med, 2022, 61(12): 1357-1359. DOI: 10.3760/cma.j.cn112138-20220121-00068
|
| [10] |
Koulouri O, Moran C, Halsall D, et al. Pitfalls in the measurement and interpretation of thyroid function tests[J]. Best Pract Res Clin Endocrinol Metab, 2013, 27(6): 745-762. DOI: 10.1016/j.beem.2013.10.003
|
| [11] |
Yao B Q, Wei Y J, Zhang S C, et al. Revealing a mutant-induced receptor allosteric mechanism for the thyroid hormone resistance[J]. iScience, 2019, 20: 489-496. DOI: 10.1016/j.isci.2019.10.002
|
| [12] |
Haraguchi T, Hamamoto Y, Kuwata H, et al. Effect of roxadustat on thyroid function in patients with renal anemia[J]. J Clin Endocrinol Metab, 2023, 109(1): e69-e75. DOI: 10.1210/clinem/dgad483
|
| [13] |
Varghese T, Rejish Kumar V, Anand G, et al. Dietary GABA enhances hypoxia tolerance of bottom-dwelling carp, cirrhinus mrigala by modulating HlF-1α, thyroid hormones and metabolicresponses[J]. Fish Physiol Biochem, 2020, 46(1): 199-212. DOI: 10.1007/s10695-019-00708-4
|
| [1] | YAN Xinchun, HUO Li. Evaluation of Von Hippel-Lindau Syndrome Through Novel Small Molecular Tracer 68Ga-NY104 PET/CT Imaging[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 911-915. DOI: 10.12290/xhyxzz.2024-0216 |
| [2] | WEI Jiaojiao, LIU Shiwei, DUAN Ruixue, LI Nan, WANG Jiangna. Effects of Vaspin on Pancreatic Beta Cell Function in Type 2 Diabetic Rats by AMPK/mTOR Autophagy Signaling Pathway[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 543-552. DOI: 10.12290/xhyxzz.2022-0183 |
| [3] | WU Ling-ge, XU Yan, LI Nai-shi. Thyrotoxicosis Related to Immune Checkpoint Inhibitors[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(1): 129-135. DOI: 10.3969/j.issn.1674-9081.2020.00.004 |
| [4] | Ying XU, Ya-li XU, Zhe WANG, Yan LIN, Chang-jun WANG, Qiang SUN. Menopausal Hormone Therapy Increases the Risk of Breast Cancer:Interpretation on an Article Published in the Lancet Sep. 2019[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(5): 621-625. DOI: 10.3969/j.issn.1674-9081.2020.05.020 |
| [5] | Shi CHEN, Xiao-lan LIAN, Xue-yan WU, Xiao-feng CHAI, Xiao-ping XING. Serum Creatinine Level and Its Influencing Factors in Patients with Primary Hypothyroidism[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(6): 410-414. DOI: 10.3969/j.issn.1674-9081.2015.06.003 |
| [6] | Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006 |
| [8] | Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004 |
| [9] | Xu ZHANG, Yong-sheng TIAN, Xiao-wei CHEN, Hong JIANG. Mitochondrial 12S rRNA Mutations Related to Drug-induced Hearing Loss[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(2): 185-189. DOI: 10.3969/j.issn.1674-9081.2012.02.012 |
| [10] | Jian SUN, Wen-bo LI, Di YANG, Yin CHENG, Quan-cai CUI. Clinicopathological Characteristics of Poorly Differentiated Thyroid Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 72-76. DOI: 10.3969/j.issn.1674-9081.2012.01.016 |
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: